As shown in Figures 1(a) and 1(b), PBRM1 was upregulated in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), lymphoid neoplasm diffuse large B cell lymphoma (DLBC), acute myeloid leukemia (LAML), glioblastoma multiforme (GBM), brain's lower grade glioma (LGG), pancreatic adenocarcinoma (PAAD), ovarian serous cystadenocarcinoma (OV), and thymoma (THYM). This evidence concerns the gene PBRM1 and cholangiocarcinoma.